Bone, Drug development, Drugs in development, EHA 2010, Europe, Haematology oncology, T...

Flash player required  Flash player required

You do not have the correct version of the flash player required to view this content. Click here to install the free Adobe flash player.

Prof Danilo Perrotti - The Ohio State University, USA

MicroRNA as a treatment for chronic myelogenous leukaemia

Prof Perrotti speaks about the discovery that microRNA can be used to bind to proteins and block their function. Initial results suggest this could be an effective way of treating myeloid leukaemia. The microRNA miR-328 is added to cells in blast crisis where they block the protein C/EBP alpha, causing the blast cells to differentiate and die. Prof Perrotti discusses his hopes for the development of this treatment and explains the difficulties that may be faced translating these results into clinical practice.

Views: 1055   Added: 20/07/2010    Comments: 0

00:02:56

15 Ratings 
  • Currently 2/5 Stars.
  • 1
  • 2
  • 3
  • 4
  • 5
Bookmark and Share

Comments on this video Report unsuitable comment

No comments have been made on this video yet, be the first to voice your opinion, use the form on the right.

Add a comment